{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:42:47Z","timestamp":1777401767218,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13014-018-1024-z","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T08:04:39Z","timestamp":1525766679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Patterns of failure after resection of extrahepatic bile duct cancer: implications for adjuvant radiotherapy indication and treatment volumes"],"prefix":"10.1186","volume":"13","author":[{"given":"Hoon Sik","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Mun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bae Kwon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hojin","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Bong","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Gyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6433-7011","authenticated-orcid":false,"given":"Jin Ho","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"key":"1024_CR1","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/ijc.28161","volume":"133","author":"FA Castro","year":"2013","unstructured":"Castro FA, Koshiol J, Hsing AW, Devesa SS. Biliary tract cancer incidence in the United States-demographic and temporal variations by anatomic site. Int J Cancer. 2013;133:1664\u201371.","journal-title":"Int J Cancer"},{"key":"1024_CR2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000453013","volume":"32","author":"MM Kirstein","year":"2016","unstructured":"Kirstein MM, Vogel A. Epidemiology and risk factors of cholangiocarcinoma. Visc Med. 2016;32:395\u2013400.","journal-title":"Visc Med"},{"key":"1024_CR3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1349-7006.2009.01458.x","volume":"101","author":"HR Shin","year":"2010","unstructured":"Shin HR, Oh JK, Masuyer E, Curado MP, Bouvard V, Fang YY, Wiangnon S, Sripa B, Hong ST. Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci. 2010;101:579\u201385.","journal-title":"Cancer Sci"},{"key":"1024_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1055\/s-2004-828889","volume":"24","author":"Y Shaib","year":"2004","unstructured":"Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004;24:115\u201325.","journal-title":"Semin Liver Dis"},{"key":"1024_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1148\/radiology.160.1.3520654","volume":"160","author":"RN Gibson","year":"1986","unstructured":"Gibson RN, Yeung E, Thompson JN, Carr DH, Hemingway AP, Bradpiece HA, Benjamin IS, Blumgart LH, Allison DJ. Bile duct obstruction: radiologic evaluation of level, cause, and tumor resectability. Radiology. 1986;160:43\u20137.","journal-title":"Radiology"},{"key":"1024_CR6","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1002\/1097-0142(19920915)70:6<1498::AID-CNCR2820700609>3.0.CO;2-C","volume":"70","author":"DE Henson","year":"1992","unstructured":"Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade, and survival rates. Cancer. 1992;70:1498\u2013501.","journal-title":"Cancer"},{"key":"1024_CR7","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","volume":"30","author":"AM Horgan","year":"2012","unstructured":"Horgan AM, Amir E, Walter T, Knox JJ. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol. 2012;30:1934\u201340.","journal-title":"J Clin Oncol"},{"issue":"Suppl 3","key":"1024_CR8","doi-asserted-by":"publisher","first-page":"S1133","DOI":"10.1245\/s10434-015-4599-8","volume":"22","author":"RS Hoehn","year":"2015","unstructured":"Hoehn RS, Wima K, Ertel AE, Meier A, Ahmad SA, Shah SA, Abbott DE. Adjuvant chemotherapy and radiation therapy is associated with improved survival for patients with extrahepatic cholangiocarcinoma. Ann Surg Oncol. 2015;22(Suppl 3):S1133\u20139.","journal-title":"Ann Surg Oncol"},{"key":"1024_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jhbp.211","volume":"22","author":"M Miyazaki","year":"2015","unstructured":"Miyazaki M, Ohtsuka M, Miyakawa S, Nagino M, Yamamoto M, Kokudo N, Sano K, Endo I, Unno M, Chijiiwa K, Horiguchi A, et al. Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition. J Hepatobiliary Pancreat Sci. 2015;22:181\u201396.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"1024_CR10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejso.2004.08.013","volume":"31","author":"SS Sikora","year":"2005","unstructured":"Sikora SS, Balachandran P, Dimri K, Rastogi N, Kumar A, Saxena R, Kapoor VK. Adjuvant chemo-radiotherapy in ampullary cancers. Eur J Surg Oncol. 2005;31:158\u201363.","journal-title":"Eur J Surg Oncol"},{"key":"1024_CR11","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1097\/00000658-199506000-00017","volume":"221","author":"HA Pitt","year":"1995","unstructured":"Pitt HA, Nakeeb A, Abrams RA, Coleman J, Piantadosi S, Yeo CJ, Lillemore KD, Cameron JL. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg. 1995;221:788\u201397. discussion 97-8","journal-title":"Ann Surg"},{"key":"1024_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ijrobp.2006.11.048","volume":"68","author":"MA Hughes","year":"2007","unstructured":"Hughes MA, Frassica DA, Yeo CJ, Riall TS, Lillemoe KD, Cameron JL, Donehower RC, Laheru DA, Hruban RH, Abrams RA. Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. Int J Radiat Oncol Biol Phys. 2007;68:178\u201382.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1024_CR13","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.ijrobp.2006.04.018","volume":"66","author":"S Bhatia","year":"2006","unstructured":"Bhatia S, Miller RC, Haddock MG, Donohue JH, Krishnan S. Adjuvant therapy for ampullary carcinomas: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 2006;66:514\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1024_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.4143\/crt.2016.166","volume":"49","author":"BH Kim","year":"2017","unstructured":"Kim BH, Kim K, Chie EK, Kwon J, Jang JY, Kim SW, Oh DY, Bang YJ. Long-term outcome of distal cholangiocarcinoma after Pancreaticoduodenectomy followed by adjuvant Chemoradiotherapy: a 15-year experience in a single institution. Cancer Res Treat. 2017;49:473\u201383.","journal-title":"Cancer Res Treat"},{"key":"1024_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ijrobp.2008.07.008","volume":"73","author":"JW Nelson","year":"2009","unstructured":"Nelson JW, Ghafoori AP, Willett CG, Tyler DS, Pappas TN, Clary BM, Hurwitz HI, Bendell JC, Morse MA, Clough RW, Czito BG. Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys. 2009;73:148\u201353.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1024_CR16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.ijrobp.2017.06.2467","volume":"99","author":"Z Ghiassi-Nejad","year":"2017","unstructured":"Ghiassi-Nejad Z, Tarchi P, Moshier E, Ru M, Tabrizian P, Schwartz M, Buckstein M. Prognostic factors and patterns of Locoregional failure after surgical resection in patients with cholangiocarcinoma without adjuvant radiation therapy: optimal field Design for Adjuvant Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017;99:805\u201311.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1024_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ijrobp.2003.11.003","volume":"59","author":"MT Milano","year":"2004","unstructured":"Milano MT, Chmura SJ, Garofalo MC, Rash C, Roeske JC, Connell PP, Kwon OH, Jani AB, Heimann R. Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys. 2004;59:445\u201353.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1024_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.radonc.2011.05.016","volume":"99","author":"FA Polistina","year":"2011","unstructured":"Polistina FA, Guglielmi R, Baiocchi C, Francescon P, Scalchi P, Febbraro A, Costantin G, Ambrosino G. Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience. Radiother Oncol. 2011;99:120\u20133.","journal-title":"Radiother Oncol"},{"key":"1024_CR19","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S0360-3016(02)02952-8","volume":"54","author":"S Kim","year":"2002","unstructured":"Kim S, Kim SW, Bang YJ, Heo DS, Ha SW. Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys. 2002;54:414\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1024_CR20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0360-3016(99)00472-1","volume":"46","author":"T Todoroki","year":"2000","unstructured":"Todoroki T, Ohara K, Kawamoto T, Koike N, Yoshida S, Kashiwagi H, Otsuka M, Fukao K. Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma. Int J Radiat Oncol Biol Phys. 2000;46:581\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1024_CR21","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1200\/JCO.2014.60.2219","volume":"33","author":"E Ben-Josef","year":"2015","unstructured":"Ben-Josef E, Guthrie KA, El-Khoueiry AB, Corless CL, Zalupski MM, Lowy AM, Thomas CR Jr, Alberts SR, Dawson LA, Micetich KC, Thomas MB, et al. SWOG S0809: a phase II intergroup trial of adjuvant Capecitabine and gemcitabine followed by radiotherapy and concurrent Capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma. J Clin Oncol. 2015;33:2617\u201322.","journal-title":"J Clin Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1024-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-018-1024-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1024-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T19:44:23Z","timestamp":1557258263000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-018-1024-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1024"],"URL":"https:\/\/doi.org\/10.1186\/s13014-018-1024-z","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,8]]},"assertion":[{"value":"23 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Boards (IRBs) of Gyeongsang National University Hospital (IRB No. GNUH 2017\u201312-015) and Samsung Changwon Hospital (IRB No. SCMC 2017\u201305-007).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"85"}}